首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1677篇
  免费   125篇
  2023年   18篇
  2022年   29篇
  2021年   67篇
  2020年   45篇
  2019年   52篇
  2018年   68篇
  2017年   40篇
  2016年   49篇
  2015年   89篇
  2014年   109篇
  2013年   107篇
  2012年   146篇
  2011年   113篇
  2010年   72篇
  2009年   55篇
  2008年   64篇
  2007年   68篇
  2006年   54篇
  2005年   41篇
  2004年   44篇
  2003年   32篇
  2002年   30篇
  2001年   19篇
  2000年   27篇
  1999年   19篇
  1998年   7篇
  1996年   8篇
  1995年   7篇
  1994年   7篇
  1993年   6篇
  1992年   22篇
  1991年   17篇
  1990年   11篇
  1989年   22篇
  1988年   18篇
  1987年   8篇
  1986年   25篇
  1985年   12篇
  1984年   16篇
  1983年   15篇
  1982年   6篇
  1981年   13篇
  1980年   12篇
  1979年   10篇
  1978年   12篇
  1976年   11篇
  1975年   8篇
  1974年   9篇
  1973年   10篇
  1972年   16篇
排序方式: 共有1802条查询结果,搜索用时 31 毫秒
81.
82.
83.
84.
Atypical hemolytic uremic syndrome (aHUS) is associated with defective complement regulation. Disease-associated mutations have been described in the genes encoding the complement regulators complement factor H, membrane cofactor protein, factor B, and factor I. In this study, we show in two independent cohorts of aHUS patients that deletion of two closely related genes, complement factor H-related 1 (CFHR1) and complement factor H-related 3 (CFHR3), increases the risk of aHUS. Amplification analysis and sequencing of genomic DNA of three affected individuals revealed a chromosomal deletion of approximately 84 kb in the RCA gene cluster, resulting in loss of the genes coding for CFHR1 and CFHR3, but leaving the genomic structure of factor H intact. The CFHR1 and CFHR3 genes are flanked by long homologous repeats with long interspersed nuclear elements (retrotransposons) and we suggest that nonallelic homologous recombination between these repeats results in the loss of the two genes. Impaired protection of erythrocytes from complement activation is observed in the serum of aHUS patients deficient in CFHR1 and CFHR3, thus suggesting a regulatory role for CFHR1 and CFHR3 in complement activation. The identification of CFHR1/CFHR3 deficiency in aHUS patients may lead to the design of new diagnostic approaches, such as enhanced testing for these genes.  相似文献   
85.
86.
87.

Data centers, clusters, and grids have historically supported High-Performance Computing (HPC) applications. Due to the high capital and operational expenditures associated with such infrastructures, we have witnessed consistent efforts to run HPC applications in the cloud in the recent past. The potential advantages of this shift include higher scalability and lower costs. If, on the one hand, app instantiation—through customized Virtual Machines (VMs)—is a well-solved issue, on the other, the network still represents a significant bottleneck. When switching HPC applications to be executed on the cloud, we lose control of where VMs will be positioned and of the paths that will be traversed for processes to communicate with one another. To bridge this gap, we present Janus, a framework for dynamic, just-in-time path provisioning in cloud infrastructures. By leveraging emerging software-defined networking principles, the framework allows for an HPC application, once deployed, to have interprocess communication paths configured upon usage based on least-used network links (instead of resorting to shortest, pre-computed paths). Janus is fully configurable to cope with different operating parameters and communication strategies, providing a rich ecosystem for application execution speed up. Through an extensive experimental evaluation, we provide evidence that the proposed framework can lead to significant gains regarding runtime. Moreover, we show what one can expect in terms of system overheads, providing essential insights on how better benefiting from Janus.

  相似文献   
88.
Photosynthesis Research - This study examined whether drought sensitivity in açaí (Euterpe oleracea Mart.) is associated with reductions in photosynthesis and increasing oxidative stress...  相似文献   
89.
90.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号